[HTML][HTML] Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement
E Alvarez-Cuesta, R Madrigal-Burgaleta… - World Allergy …, 2022 - Elsevier
Drug hypersensitivity reactions (DHRs) to intravenous drugs can be severe and might leave
patients and doctors in a difficult position where an essential treatment or intervention has to …
patients and doctors in a difficult position where an essential treatment or intervention has to …
Rituximab hypersensitivity: from clinical presentation to management
GE Fouda, S Bavbek - Frontiers in pharmacology, 2020 - frontiersin.org
Rituximab is a chimeric monoclonal antibody (mAb) against CD20 molecule which is
expressed on human B cells. It has been used for the treatment of various lymphoid …
expressed on human B cells. It has been used for the treatment of various lymphoid …
[HTML][HTML] Evidence-and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria
Purpose Phenylketonuria (PKU) is a rare metabolic disorder that requires life-long
management to reduce phenylalanine (Phe) concentrations within the recommended range …
management to reduce phenylalanine (Phe) concentrations within the recommended range …
Rapid drug desensitization with biologics: a single-center experience with four biologics
Background: Rapid drug desensitization (RDD) induces a temporary tolerance to biologics
which induce hypersensitivity reactions (HSRs). Data are limited regarding the use of RDD …
which induce hypersensitivity reactions (HSRs). Data are limited regarding the use of RDD …
[PDF][PDF] Desensitization to biological agents used in rheumatology
J Makowska, A Lewandowska-Polak - Reumatologia/Rheumatology, 2020 - termedia.pl
Biological agents such as monoclonal antibodies and fusion proteins are widely used for the
treatment of patients with various rheumatic disorders, influencing the quality of life, disability …
treatment of patients with various rheumatic disorders, influencing the quality of life, disability …
[PDF][PDF] Rapid Drug Desensitization with Rituximab in 24 Cases: Single-Center Experience
S Bavbek - J Investig Allergol Clin Immunol, 2019 - scholar.archive.org
Rapid Drug Desensitization with Rituximab in 24 Cases: Single-Center Experience Görgülü
B1, Cengiz Seval G2, Kendirlinan R1, Page 1 1 J Investig Allergol Clin Immunol 2019; Vol …
B1, Cengiz Seval G2, Kendirlinan R1, Page 1 1 J Investig Allergol Clin Immunol 2019; Vol …
Interdisciplinary Healthcare Team Experience of Carboplatin and Oxaliplatin Desensitizations in a Tertiary Referral University Hospital
C Tunakan Dalgic, A Camyar… - Journal of Asthma …, 2023 - Taylor & Francis
Purpose Repeated exposure to platinum compounds increases the risk of immunoglobulin E-
mediated immediate hypersensitivity reactions (HSR). To date, many different …
mediated immediate hypersensitivity reactions (HSR). To date, many different …
Hypersensitivity Reactions to Monoclonal Antibodies: New Approaches
S Gelis, JT Verdesoto, M Pascal… - … Treatment Options in …, 2022 - Springer
Purpose of review Adverse reactions to monoclonal antibodies are increasing in parallel
with the development of new ones. Hypersensitivity reactions related with these drugs are …
with the development of new ones. Hypersensitivity reactions related with these drugs are …
Desensytyzacja na leki biologiczne stosowane w reumatologii
J Makowska, A Lewandowska-Polak - Reumatologia, 2020 - reu.termedia.pl
Biological agents such as monoclonal antibodies and fusion proteins are widely used for the
treatment of patients with various rheumatic disorders, influencing the quality of life, disability …
treatment of patients with various rheumatic disorders, influencing the quality of life, disability …